Clinical Trials Directory

Trials / Unknown

UnknownNCT04507945

Stablishment of Prevention and Treatment System for Intestinal Dysfunction

The Goal-direct Treatment of Chronic Bowel Dysfunction

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Nanjing University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Dysfunction and intestinal endocrine dysfunction. This project will use genomics, metabonomics, microbiome and other omics techniques to study the clinical pathway of CID integrated therapy.

Conditions

Interventions

TypeNameDescription
DRUGNutritional Therapy, Metabolic Disorder, RegularAccording to the result reported by Byrne, Wilmore, etc. in 1992 \~ 1995, the use of growth hormone, glutamine, modified diet and other measures proposed intestinal rehabilitation treatment. Then, check the patient's quality of life survey, nutritional status, inflammation indicators and other changes every three months, and use metabolomics and microbiomic tools to detect changes in the patient's nutritional metabolism, intestinal microecology, etc., and adjust the patient's nutritional treatment and microecological treatment based on the results Program.

Timeline

Start date
2020-10-01
Primary completion
2021-09-30
Completion
2023-09-30
First posted
2020-08-11
Last updated
2020-08-11

Source: ClinicalTrials.gov record NCT04507945. Inclusion in this directory is not an endorsement.

Stablishment of Prevention and Treatment System for Intestinal Dysfunction (NCT04507945) · Clinical Trials Directory